Header Logo

Connection

Sonal Singh to Glucagon-Like Peptide 1

This is a "connection" page, showing publications Sonal Singh has written about Glucagon-Like Peptide 1.
Connection Strength

0.986
  1. Singh S. Glucagon-like peptide 1-based drugs and pancreatic safety--reply. JAMA Intern Med. 2013 Oct 28; 173(19):1843-4.
    View in: PubMed
    Score: 0.481
  2. Singh S, Chang HY, Richards TM, Weiner JP, Clark JM, Segal JB. Glucagonlike peptide 1-based therapies and risk of hospitalization for acute pancreatitis in type 2 diabetes mellitus: a population-based matched case-control study. JAMA Intern Med. 2013 Apr 08; 173(7):534-9.
    View in: PubMed
    Score: 0.463
  3. Chang HY, Singh S, Mansour O, Baksh S, Alexander GC. Association Between Sodium-Glucose Cotransporter 2 Inhibitors and Lower Extremity Amputation Among Patients With Type 2 Diabetes. JAMA Intern Med. 2018 09 01; 178(9):1190-1198.
    View in: PubMed
    Score: 0.042
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.